As an anxiolytic, the lowest effective dose should be employed; dosage regimes should not exceed 4 weeks and treatment should be gradually withdrawn. Patients who have received benzodiazepines for a long time may require an extended withdrawal period. Long-term chronic use is not recommended.
Alternative presentations of diazepam are recommended for pediatric usage in order to obtain suitable doses of less than 5mg.
Spastic children with minimal brain damage: 5-40mg daily in divided doses.
Diazepam is contra-indicated for patients with:
• Hypersensitivity to the active substance, benzodiazepines, or to any of the excipients listed in section 6.1.
• Phobic or obsessional states; chronic psychosis, hyperkinesis (paradoxical reactions may occur)
• Acute pulmonary insufficiency; respiratory depression, acute or chronic severe respiratory insufficiency (ventilatory failure may be exacerbated)
• Myasthenia gravis (condition may be exacerbated)
• Sleep apnoea (condition may be exacerbated)
|Medical License Required||Yes|
|Route of Administration||Oral|
|Therapeutic Class||Anxiety Disorders|
|Unit of Measure||Bottle|